The global Tumor-Agnostic Oncology Drug Market is at the forefront of the precision medicine revolution, shifting the focus of cancer treatment from the tumor's site of origin to its specific genetic mutations and biomarkers. This innovative approach offers hope for patients with rare cancers or those whose tumors harbor specific molecular alterations, providing more effective and tar... https://www.databridgemarketresearch.com/